OTC Pharmaceuticals - Scandinavia Industry Guide

Published by: Datamonitor

Published: Aug. 1, 2009 - 92 Pages

Table of Contents

CHAPTER 1 INTRODUCTION

1.1 What is this report about?

1.2 Who is the target reader?

1.3 How to use this report

1.4 Definitions

CHAPTER 2 SCANDINAVIA OTC PHARMACEUTICALS INDUSTRY OUTLOOK

2.1 Market Analysis

2.2 Market Revenues

2.3 Market Segmentation

CHAPTER 3 OTC PHARMACEUTICALS IN DENMARK

3.1 Market Overview

3.2 Market Value

3.3 Market Segmentation I

3.4 Market Segmentation II

3.5 Market Share

3.6 Five Forces Analysis

3.7 Leading Companies

3.8 Distribution

3.9 Market Forecasts

3.10 Macroeconomic Indicators

CHAPTER 4 OTC PHARMACEUTICALS IN NORWAY

4.1 Market Overview

4.2 Market Value

4.3 Market Segmentation I

4.4 Market Segmentation II

4.5 Market Share

4.6 Five Forces Analysis

4.7 Leading Companies

4.8 Distribution

4.9 Market Forecasts

4.10 Macroeconomic Indicators

CHAPTER 5 OTC PHARMACEUTICALS IN SWEDEN

5.1 Market Overview

5.2 Market Value

5.3 Market Segmentation I

5.4 Market Segmentation II

5.5 Market Share

5.6 Five Forces Analysis

5.7 Leading Companies

5.8 Distribution

5.9 Market Forecasts

5.10 Macroeconomic Indicators

CHAPTER 6 APPENDIX

6.1 Data Research Methodology

LIST OF TABLES

Table 1: Scandinavia OTC Pharmaceuticals industry, revenue ($ bn) 2004-2013

Table 2: Scandinavia OTC Pharmaceuticals industry, revenue ($ bn) 2004-2008(e)

Table 3: Scandinavia OTC Pharmaceuticals industry forecast, revenue ($ bn) 2008-2013

Table 4: Denmark OTC Pharmaceuticals Market Value: $ million, 2004-2008(e)

Table 5: Denmark OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 6: Denmark OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 7: Denmark OTC Pharmaceuticals Market Share: % Share, by Value, 2007

Table 8: Key Facts: Novartis AG

Table 9: Key Financials: Novartis AG

Table 10: Key Facts: Pfizer Inc

Table 11: Key Financials: Pfizer Inc

Table 12: Key Facts: GlaxoSmithKline PLC

Table 13: Key Financials: GlaxoSmithKline PLC

Table 14: Denmark OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)

Table 15: Denmark OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013

Table 16: Denmark Size of Population (million), 2004-2008(e)

Table 17: Denmark GDP (Constant 2000 Prices, $ billion), 2004-2008(e)

Table 18: Denmark Inflation, 2004-2008(e)

Table 19: Denmark Exchange Rate, 2004-2008(e)

Table 20: Norway OTC Pharmaceuticals Market Value: $ million, 2004-2008(e)

Table 21: Norway OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 22: Norway OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 23: Norway OTC Pharmaceuticals Market Share: % Share, by Value, 2007

Table 24: Key Facts: GlaxoSmithKline PLC

Table 25: Key Financials: GlaxoSmithKline PLC

Table 26: Key Facts: Pfizer Inc

Table 27: Key Financials: Pfizer Inc

Table 28: Key Facts: Novartis AG

Table 29: Key Financials: Novartis AG

Table 30: Norway OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)

Table 31: Norway OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013

Table 32: Norway Size of Population (million), 2004-2008(e)

Table 33: Norway GDP (Constant 2000 Prices, $ billion), 2004-2008(e)

Table 34: Norway Inflation, 2004-2008(e)

Table 35: Norway Exchange Rate, 2004-2008(e)

Table 36: Sweden OTC Pharmaceuticals Market Value: $ million, 2004-2008(e)

Table 37: Sweden OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Table 38: Sweden OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Table 39: Sweden OTC Pharmaceuticals Market Share: % Share, by Value, 2007

Table 40: Key Facts: Pfizer Inc

Table 41: Key Financials: Pfizer Inc

Table 42: Key Facts: Bayer AG

Table 43: Key Financials: Bayer AG

Table 44: Key Facts: Novartis AG

Table 45: Key Financials: Novartis AG

Table 46: Sweden OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)

Table 47: Sweden OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013

Table 48: Sweden Size of Population (million), 2004-2008(e)

Table 49: Sweden GDP (Constant 2000 Prices, $ billion), 2004-2008(e)

Table 50: Sweden Inflation, 2004-2008(e)

Table 51: Sweden Exchange Rate, 2004-2008(e)

LIST OF FIGURES

Figure 1: Scandinavia OTC Pharmaceuticals industry, revenue ($ bn) 2004-2013

Figure 2: Scandinavia OTC Pharmaceuticals industry, revenue ($ bn) 2004-2008(e)

Figure 3: Scandinavia OTC Pharmaceuticals industry forecast, revenue ($ bn) 2008-2013

Figure 4: Scandinavia OTC Pharmaceuticals industry, Segmentation (%) 2008

Figure 5: Denmark OTC Pharmaceuticals Market Value: $ million, 2004-2008(e)

Figure 6: Denmark OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 7: Denmark OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 8: Denmark OTC Pharmaceuticals Market Share: % Share, by Value, 2007

Figure 9: Forces Driving Competition in the OTC Pharmaceuticals Market in Denmark

Figure 10: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Denmark

Figure 11: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Denmark

Figure 12: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Denmark

Figure 13: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Denmark

Figure 14: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Denmark

Figure 15: Revenues & Profitability: Novartis AG

Figure 16: Revenues & Profitability: Pfizer Inc

Figure 17: Revenues & Profitability: GlaxoSmithKline PLC

Figure 18: Denmark OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)

Figure 19: Denmark OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013

Figure 20: Norway OTC Pharmaceuticals Market Value: $ million, 2004-2008(e)

Figure 21: Norway OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 22: Norway OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 23: Norway OTC Pharmaceuticals Market Share: % Share, by Value, 2007

Figure 24: Forces Driving Competition in the OTC Pharmaceuticals Market in Norway

Figure 25: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Norway

Figure 26: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Norway

Figure 27: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Norway

Figure 28: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Norway

Figure 29: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Norway

Figure 30: Revenues & Profitability: GlaxoSmithKline PLC

Figure 31: Revenues & Profitability: Pfizer Inc

Figure 32: Revenues & Profitability: Novartis AG

Figure 33: Norway OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)

Figure 34: Norway OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013

Figure 35: Sweden OTC Pharmaceuticals Market Value: $ million, 2004-2008(e)

Figure 36: Sweden OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)

Figure 37: Sweden OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)

Figure 38: Sweden OTC Pharmaceuticals Market Share: % Share, by Value, 2007

Figure 39: Forces Driving Competition in the OTC Pharmaceuticals Market in Sweden

Figure 40: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Sweden

Figure 41: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Sweden

Figure 42: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Sweden

Figure 43: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Sweden

Figure 44: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Sweden

Figure 45: Revenues & Profitability: Pfizer Inc

Figure 46: Revenues & Profitability: Bayer AG

Figure 47: Revenues & Profitability: Novartis AG

Figure 48: Sweden OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e)

Figure 49: Sweden OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013

Abstract

• Contains an executive summary market values, and segmentation
• Provides textual analysis of the industry's prospects, competitive landscape and profiles of leading companies
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Compares data from Denmark, Norway and Sweden, alongside individual chapters on each country. .
• Includes a five-year forecast of the industry

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.